Status:
COMPLETED
Long-term Outcomes in Terms of Disability and Quality of Life for Patients Undergoing Posterior Cranial Fossa Craniectomy in the Context of Compressive Cerebellar Hematoma
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Craniectomy
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Posterior cranial fossa craniectomy has been shown to improve patient survival. The level of autonomy, disability and quality of life of survivors has been little studied and still underresearched,. ...
Detailed Description
Investigators are carrying out a retrospective observational, single-center study, in three intensive care units in the Grenoble Hospital Center. Every patients who underwent a posterior fossa craniec...
Eligibility Criteria
Inclusion
- Patient who underwent a posterior cranial fossa craniectomy in the context of an acute cerebellar hematoma between January 01, 2012 to January 01, 2020.
- Adult man or woman
- Hospitalized in intensive care
- No opposition from the patient or a loved one to a telephone contact to determine the SF36 (The Short Form) quality of life scale, from the medical outcome study.
Exclusion
- Subject under guardianship or subject deprived of liberty
- Early limitation of active therapy before 48 hours.
Key Trial Info
Start Date :
December 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04672785
Start Date
December 17 2020
End Date
May 12 2021
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUGA
Grenoble, France, 38043